Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in HPV-18 URR E6/E7 transgenic mice

Gynecologic Oncology

Volumn 89, Issue 3, 2003, Pages 360-368

  Park, Jong Sup ^a   Rhyu, Jae Woong ^b   Kim, Chan Joo ^a   Kim, Hy Sook ^c   Lee, Sun Young ^d   Kwon, Yong Ill ^a   Namkoong, Sung Eun ^a   Sin, Hong Sig ^e   Um, Soo Jong ^f  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Korean Institute of Radiological and Medical Sciences   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Pochun Jungmun Medical College   (South Korea)

^e Milae Resources ML Co Ltd   (South Korea)

^f Sejong University   (South Korea)

Author keywords

Cervical cancer; E6; E7; Estrogen; Human papillomavirus (HPV); URR

Indexed keywords

CELL NUCLEUS ANTIGEN; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENDOMETRIUM HYPERPLASIA; EPITHELIUM CELL; ESTROGEN BLOOD LEVEL; GENETIC TRANSFECTION; GROWTH STIMULATION; HORMONAL CARCINOGENESIS; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; TRANSACTIVATION; TRANSGENIC MOUSE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX EPITHELIUM; VAGINA EPITHELIUM; VIRUS GENE; WART VIRUS;

EID: 0037498616     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(02)00106-3     Document Type: Article

References (32)

1. zur Hausen H. Human papillomavirus in the pathogenesis of anogenital cancer. Virology. 184:1991;9-14.
2. Auborn K., Woodworth C., Dipaolo J., Bradlow H.L. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis. Int J Cancer. 49:1991;867-869.
3. Bradlow H.L., Hershcopf R.J., Martucci C.P., Fishman J. Estradiol 16-α-hydroxylation in the mouse correlates with murine mammary tumor virus a possible model for the hormonal etiology of breast cancer in humans . Proc Natl Acad Sci USA. 82:1985;6295-6299.
4. Brisson J., Morin C., Roy M., Bouchard C., Leclerc J., Christen A., et al. Risk factors for cervical intraepithelial neoplasia differences between low- and high-grade lesions . Am J Epidemiol. 140:1994;700-710.
5. Ursin G., Peters R.K., Henderson B.E., d'Ablaing G. III, Monroe K.R., Pike M.C. Oral contraceptive use and adenocarcinoma of cervix. Lancet. 344:1994;1390-1394.
6. Thomas D.B., Ray R.M. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix the World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives . Am J Epidemiol. 144:1996;281-289.
7. Okagaki T., Tase T., Twiggs L.B., Carson L.F. Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen. J Reprod Med. 34:1996;639-644.
8. Duggan M.A., McGregor S.E., Benoit J.L., Inoue M., Nation J.G., Stuart G.C. The human papillomavirus status of invasive cervical adenocarcinoma a clinicopathologic status and outcome analysis . Human Pathol. 26:1995;319-325.
9. Milde-Langossch K., Schriber C., Becker G., Loning T., Stegner H.E. Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction. Human Pathol. 24:1993;590-594.
10. Yamakawa Y., Forslund O., Teshima H., Hasumi K., Kitagawa T., Hansson B.G. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction. Gynecol Oncol. 53:1994;190-195.
11. Chong T., Chan W.K., Bernard H.U. Transcriptional activation of human papillomavirus 16 by nuclear factor 1, AP-1, steroid receptors and a possibly novel transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell specific transcription. J Virol. 65:1991;5933-5943.
12. Butz K., Hoppe-Seyler F. Transcriptional control of human papillomavirus oncogene expression composition of the HPV type 18 upstream regulatory region . J Virol. 67:1993;6476-6486.
13. Mitrani-Rosenbaum S., Tsvieli R., Tu-Kuspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol. 70:1989;2227-2232.
14. Hudson J.B., Bedell M., McCance D.J., Laimins L.A. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol. 64:1990;519-526.
15. Hogan B., Constantini F., Lacy E. Manipulating the mouse embryo a laboratory manual . 1986;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
16. Um S.J., Rhyu J.W., Kim E.J., Jeon K.C., Hwang E.S., Park J.S. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett. 179:2002;205-212.
17. Crum C.P., Nuovo G.J. The cervix. Sternberg S. Diagnostic surgical pathology. 1994;2055-2090 Raven Press, New York.
18. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning. A laboratory manual. 2nd edition:1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. Munger K., Phelps W.C., Bobb V., Howley P.M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 63:1989;4417-4421.
20. Song S., Liem A., Miller J.A., Lambert P.F. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology. 267:2000;141-150.
21. Schneider A., Holz M., Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer. 40:1987;198-203.
22. Baken L.A., Koursky L.A., Kuypers J., Kosorok M.R., Lee S.K., Kiviat N.B., et al. Genital human papillomavirus infection among male and female sex partners prevalence and type-specific concordance . J Infect Dis. 171:1995;429-432.
23. Arbeit J.M., Howley P.M., Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad USA. 93:1996;2930-2935.
24. Michelin D., Gissmann L., Street D., Potkul R.K., Fisher S., Kaufmann A.M., et al. Regulation of human papillomavirus type 18 in vivo effects of estrogen and progesterone in transgenic mice . Gynecol Oncol. 66:1997;202-208.
25. Elson D.A., Riley R.R., Lacey A., Thordarson G., Talamantes F.J., Arbeit J.M. Sensitivity of the cervical transformation zone to estrogen-induced suqamous carcinogenesis. Cancer Res. 60:2000;1267-1275.
26. Kim C.J., Um S.J., Kim T.Y., Kim E.J., Park T.C., Kim S.J., et al. Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells. Int J Gynecol Cancer. 10:2000;157-164.
27. Lacey J.V. Jr, Brinton L.A., Barnes W.A., Gravitt P.E., Greenberg M.D., Hadjimichael O.C., et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol. 77:2000;149-154.
28. Liu Y., Li J.Z., Yuan X.H., Adler-Storthz K., Che Z. An AP-1 binding site mutation in HPV-16 LCR enhances E6/E7 promoter activity in human oral epithelial cells. Virus Genes. 24:2002;29-37.
29. Jin L., Qi M., Chen D.Z., Anderson A., Yang G.Y., Arbeit J.M., et al. Indole-3-carbinol prevents cervical cancer in human papillomavirus type 16 (HPV16) transgenic mice. Cancer Res. 59:1999;3991-3997.
30. Bell M.C., Crowley-Nowick P., Bradlow H.L., Sepkovic D.W., Schmidt-Grimminger D., Howell P., et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol. 78:2000;123-129.
31. Newfield L., Bradlow H.L., Sepkovic D.W., Auborn K.J. Estrogen metabolism and the malignant potential of human papillomavirus immortalized keratinocytes. Proc Soc Exp Biol Med. 217:1993;322-326.
32. Zwerschke W., Mazurek S., Massimi P., Banks L., Eigenbrodt E., Jansen-Durr P. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci USA. 96:1999;1291-1296.